Registration successful
Account activated – pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next three days.
In the meantime, you can enjoy access to all the latest news, events and resources for different therapy areas on our website.
Real Life Case Studies
Interpret the information in the case study and answer questions to diagnose and manage the patient's condition.
See how you score!
A 50-year-old female is presenting with well-defined, erythematous plaques on both feet - can you help diagnose and treat her condition to improve her sleep and social life?
Case 1: A 14-year-old male is presenting with a solitary erythematous plaque on his leg - can you help to diagnose and treat his condition so that he can confidently return to school?
Case 2: A 47-year-old male is presenting with multiple, well-defined, erythematous papules and plaques on his forearm - can you help to diagnose and treat his condition to relieve his symptoms?
What is the best TCS for your patient?
TCS Ready Reckoner is an interactive tool to aid with selection of the most appropriate GSK Product within TCS treatment for patients with pre-diagnosed common SRDs according to their characteristics. This is not a diagnostic tool.
Dermovate cream prescribing information
Dermovate ointment prescribing information
Dermovate scalp application prescribing information
Betnovate cream prescribing information
Betnovate ointment prescribing information
Betnovate scalp application prescribing information
Cutivate cream prescribing information
Cutivate ointment prescribing information
Dermovate Safety Information:1-3
Contraindications:
- Dermovate is contraindicated in children under one year of age.
- Hypersensitivity to the active substance or any of the excipients.
- The following conditions should not be treated with Dermovate: Untreated cutaneous infections, rosacea, acne vulgaris, pruritus without inflammation, perianal and genital pruritus, perioral dermatitis.
- Clobetasol is contraindicated in dermatoses in children under one year of age, including dermatitis and nappy eruptions.
- Infections of the scalp.
Adverse Reactions:
Common (≥1/100 and <1/10): Pruritus, local skin burning /skin pain.
Betnovate Safety Information:4-6
Contraindications:
The following conditions should not be treated with BETNOVATE: untreated cutaneous infections, rosacea, acne vulgaris, pruritus without inflammation, perianal and genital pruritus, perioral dermatitis, dermatoses in infants under one year of age, including dermatitis; infections of the scalp.
Adverse Reactions:
Common (≥1/100 and <1/10): Pruritus, local skin burning /skin pain.
Cutivate Safety Information:7,8
Contraindications:
The following conditions should not be treated with Cutivate Cream: untreated cutaneous infections, rosacea, acne vulgaris, perioral dermatitis, perianal and genital pruritus, pruritus without inflammation, dermatoses in infants under 3 months of age, including dermatitis and nappy rash.
Adverse Reactions:
Common (≥1/100 to <1/10): Pruritus.
Footnotes:
TCS, Topical Corticosteroids; SRDs, Steroid Responsive Dermatoses
References
- Dermovate cream prescribing information based on UK V11.
- Dermovate ointment prescribing information based on UK V11.
- Dermovate scalp application prescribing information based on UK V11.
- Betnovate cream prescribing information based on GDS10/IPI05.
- Betnovate ointment prescribing information based on GDS10/IPI05.
- Betnovate scalp application prescribing information based on GDS10/IPI05.
- Cutivate cream prescribing information based on GDS15/IPI05.
- Cutivate ointment prescribing information based on GDS15/IPI04.
Trademarks are owned by or licensed to the GSK group of companies.
©2023 GSK group of companies or its licensor.
GlaxoSmithKline Limited, Registered in Saudi Arabia.
P.O. Box 55850, Jeddah 21544, Saudi Arabia.
PM-SA-BMV-WCNT-230007 | July 2023
